MOHHealthcare · Healthcare PlansThe 19 Wall Street analysts covering Molina Healthcare, Inc. hold a median 12-month price target of $222 — -2.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 33 of 100 as at 3 Nov 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores Molina Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (89): The share price has been relatively steady.
Quality (20): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on MOH, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −2.0% from it.
Of the 20 most recent actions, 7 moved their price target up and 6 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 27 Oct 2026 | JP Morgan | Maintains | Neutral | $220 → $225 |
| 23 Oct 2026 | Barclays | Maintains | Underweight | $180 → $178 |
| 23 Oct 2026 | Morgan Stanley | Maintains | Equal-Weight | $167 → $192 |
| 23 Oct 2026 | RBC Capital | Maintains | Sector Perform | $218 → $222 |
| 23 Oct 2026 | UBS | Maintains | Neutral | $202 → $225 |
| 28 July 2026 | Wells Fargo | Maintains | Equal-Weight | $235 → $220 |
| 28 July 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 24 July 2026 | Barclays | Maintains | Underweight | — |
| 24 July 2026 | Barclays | Maintains | Underweight | $184 → $180 |
| 24 July 2026 | RBC Capital | Maintains | Sector Perform | — |
| 24 July 2026 | RBC Capital | Maintains | Sector Perform | $248 → $218 |
| 24 July 2026 | Truist Securities | Maintains | Hold | — |
| 24 July 2026 | Truist Securities | Maintains | Hold | $250 → $225 |
| 14 July 2026 | TD Cowen | Maintains | Hold | $163 → $230 |
| 14 July 2026 | TD Cowen | Maintains | Hold | — |
| 14 July 2026 | Truist Securities | Maintains | Hold | $205 → $250 |
| 14 July 2026 | Truist Securities | Maintains | Hold | — |
| 13 July 2026 | Wells Fargo | Maintains | Equal-Weight | $159 → $235 |
| 13 July 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 9 July 2026 | Barclays | Maintains | Underweight | $199 → $184 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
MOH appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Molina Healthcare, Inc. returned +49.3% against +12.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 1% of US stocks
Cheaper than 89% of US stocks
Cheaper than 34% of US stocks
Cheaper than 17% of US stocks
Higher than 22% of US stocks
Higher than 10% of US stocks
Higher than 8% of US stocks
Higher than 47% of US stocks
Higher than 30% of US stocks
Higher than 43% of US stocks
Higher than 50% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Molina Healthcare, Inc. has a market value of $10.8B and an enterprise value of $6.3B.
Revenue in the twelve months to 30 June 2026: $44.5B. The latest quarter shrank 3.5% year on year.
Net income over the same four quarters: −$7.0M, a −0.0% net margin.
Diluted earnings per share, trailing twelve months: $−0.22.
Free cash flow in the twelve months to 30 June 2026: $271.0M, after $94.0M of capital spending.
Molina Healthcare, Inc. spent $500.0M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 2387.8×; forward P/E: 21.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Molina Healthcare, Inc. employs 19,000 people — $2.3M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Molina Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Healthcare stocks, including major operators in state Medicaid programs, Affordable Care Act markets and hospital groups, jumped following the midterm results.
Why it matters — Molina Healthcare watchers may note the broad gain among stocks tied to Medicaid and Affordable Care Act markets.
A MarketWatch headline says hospital stocks rallied as drugmakers faced possible scrutiny, with the Democratic midterm victory described as potentially benefiting the nation’s largest hospitals.
Why it matters — Molina Healthcare watchers may note the political shift and its stated potential implications for hospitals, though the excerpt does not specify effects on Molina.
CNBC reports that the midterm election could reshape the outlook for companies with significant exposure to Washington, including healthcare. Democratic control of either chamber could increase investigations and oversight and give the party leverage over federal spending and must-pass legislation.
Why it matters — Molina Healthcare watchers may follow how potential changes in congressional control could affect oversight and federal spending relevant to healthcare companies.
Molina Healthcare reaffirmed its full-year 2026 adjusted earnings outlook and outlined preliminary 2027 earnings building blocks exceeding $9.50 per share. The company cited anticipated rate increases, maturing new contracts and its planned exit from the Medicare Advantage prescription drug business as supporting factors.
Why it matters — The call provides MOH watchers with an update on the company’s reaffirmed 2026 outlook and preliminary framework for 2027 earnings.
Molina Healthcare held its third-quarter 2026 earnings conference call on October 22, 2026. The excerpt lists company and conference-call participants but provides no discussion of results or outlook.
Why it matters — MOH watchers can note the call took place, but this excerpt contains no substantive financial or operating details.
The 19 Wall Street analysts covering Molina Healthcare, Inc. have a median 12-month price target of $222, with estimates ranging from $163 to $266. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 19 analysts covering Molina Healthcare, Inc., 4 rate it a Buy, 14 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Molina Healthcare, Inc. 33 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, Molina Healthcare, Inc. ranks 33 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (89 of 100).
No one can know that. What the data says: the median 12-month target from 19 analysts implies -2.0% from the last close, and Ticker Nerd's factor model ranks Molina Healthcare, Inc. 33 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Molina Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MOH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $163 to $266 over the next 12 months.
Molina Healthcare, Inc. returned +49.3% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs.
The most recent item we track (Barrons, 4 Nov 2026): "Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing.". Healthcare stocks, including major operators in state Medicaid programs, Affordable Care Act markets and hospital groups, jumped following the midterm results.
Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs. The company focuses on government-sponsored healthcare, offering Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans. Its business is organized across Medicaid, Medicare, Marketplace, and Other segments, reflecting a model centered on administering public and subsidized health benefits. Molina Healthcare Inc. serves members across multiple U.S. states and plays a significant role in coordinating access to medical care, benefits administration, and healthcare network management. Founded in 1980 and headquartered in Long Beach, California, Molina Healthcare Inc. is a major participant in the U.S. managed healthcare market.
CEO Mr. Joseph Michael Zubretsky · 19,000 employees · United States · https://www.molinahealthcare.com
